Is the bladder cancer embryonic antigen high?

Written by Liu Liang
Oncology
Updated on September 03, 2024
00:00
00:00

Carcinoembryonic antigen (CEA) is significantly elevated, mainly seen in gastrointestinal tumors, especially in colorectal cancers such as colon and rectal cancers, where CEA elevation is more pronounced. It can also be notably higher in patients with lung adenocarcinoma, and bladder cancer might show an increase in CEA as well. However, the increase in CEA is not necessarily consistent, and its diagnostic value for bladder cancer is limited due to low specificity and sensitivity, making it not very instructive. The definitive diagnosis of bladder cancer primarily involves cystoscopy and taking a biopsy to confirm the presence of cancer.

Other Voices

doctor image
home-news-image
Written by Liu Liang
Oncology
40sec home-news-image

What are the symptoms of bladder cancer?

Bladder cancer's most common symptom is a consistent presence of painless gross hematuria. Some patients also exhibit frequent urination, urgency, and pain during urination as initial signs of bladder irritation. In advanced local stages, palpable pelvic tumors can be detected in patients, with symptoms such as urinary retention, lower abdominal pain, and inability to urinate. In the late stages of bladder cancer, patients may experience weight loss, back and flank pain, and signs of renal failure among other clinical manifestations.

doctor image
home-news-image
Written by Liu Liang
Oncology
24sec home-news-image

How is bladder cancer caused?

The causes of bladder cancer are not very clear so far, and they are related to factors such as environment, genetics, and lifestyle habits. However, two major risk factors are quite clear: one is smoking, and the other is long-term exposure to aromatic amines, which are occupational factors that are significant risks for causing bladder cancer.

doctor image
home-news-image
Written by Liu Liang
Oncology
1min 7sec home-news-image

Does bladder cancer require the removal of the bladder?

Whether or not to remove the entire bladder in cases of bladder cancer depends on whether the tumor has invaded the base layer and whether there is distant metastasis. For non-muscle invasive bladder cancer, where the muscle layer is not invaded and there is no distant metastasis, typically found in stage 0 and stage 1 bladder cancer patients, there is no need for complete removal of the bladder. The standard treatment in such cases generally involves transurethral resection of the bladder tumor. If the tumor has invaded the base layer but there is no distant metastasis, termed muscle-invasive bladder cancer, patients in this category require radical cystectomy, which involves the removal of the entire bladder. If there is distant metastasis, termed metastatic bladder cancer, surgical treatment is not pursued; instead, palliative chemotherapy is the primary approach.

doctor image
home-news-image
Written by Liu Liang
Oncology
41sec home-news-image

Is there a benign form of bladder cancer?

Tumors are divided into two main categories: benign tumors and malignant tumors. The malignant tumors that occur in epithelial tissues are called cancers, such as lung cancer, bladder cancer, and breast cancer. Therefore, bladder cancer is malignant; there are no benign bladder cancers. Cancer, in contrast to benign tumors, tends to metastasize to distant locations, grow rapidly, and can spread through blood, lymph nodes, and local invasion. Thus, it is termed as cancer and is malignant, which means there is no such thing as benign bladder cancer.

doctor image
home-news-image
Written by Wang Jian
Urology
49sec home-news-image

Is bladder cancer hereditary?

Bladder cancer is the most common malignant tumor in urology, occurring on the mucosa of the bladder and is also one of the top ten common tumors globally. The etiology of bladder cancer is complex, involving both intrinsic genetic factors and external environmental factors, which gives bladder cancer a hereditary tendency. Notable among the major risk factors are smoking and occupational exposure to aromatic amines, with 30% to 50% of bladder cancers caused by smoking. The incidence of bladder cancer significantly increases with the duration of smoking. The initial clinical manifestation of bladder cancer is usually hematuria, typically painless and intermittent gross hematuria. The presence of blood in urine should prompt further diagnostic testing to rule out malignant tumors in the bladder.